Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 137-144

  Cornford, Philip ^a,b   Evans, Jim ^a   Dodson, Andrew ^a   Parsons, Keith ^b   Woolfenden, Alan ^b   Neoptolemos, John ^a   Foster, Christopher S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; ISOENZYME; PROTEIN KINASE C;

ADULT; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER DIAGNOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0032894014     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65260-1     Document Type: Article

References (48)

1. Lord JM, Pongracz J: Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis. Clin Mol Pathol 1995, 48:57-64
2. Clemens MJ, Trayner I, Meneya J: The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J Cell Sci 1992, 103:881-887
3. Freed E: A novel intergrin β subunit is associated with the vitronectin receptor α-subunit (α-ν) in a human osteosarcoma cell line and is a substrate for protein kinase C. EMBO J 1989, 8:2955-2965
4. 2+-phospholipid-dependent protein kinase in rat islets and hamster β cells. Biochem J 1984, 219:547-551
5. Owen PJ, Johnson GD, Lord JM: Protein kinase C-delta associates with vimentin intermediate filaments in differentiated HL-60 cells. Exp Cell Res 1996, 225:366-373
6. Berry N, Nishizuka Y: Protein kinase C and T cell activation. European Journal of Biochemistry 1990, 189:205-214
7. Pongracz J, Johnson GD, Crocker J, Burnett D, Lord JM: The role of protein kinase C in myeloid cell apoptosis. Biochem Soc Trans 1994, 22:593-597
8. Dekker LV, Parker PJ: Protein kinase C: a question of specificity. Trends in Biochemical Science 1994, 19:73-77
9. Mochley-Rosen D, Gordon AS: Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 1998, 12:35-42
10. Mochley-Rosen D, Khaner H Lopez J: Identification of intracellular receptor proteins for activated protein kinase. Proc Natl Acad Sci USA 1991, 88:3997-4000
11. Leach KL, Powers EA, Ruff VA, Jaken S, Kaufmann S: Type 3 protein kinase C localisation to the nuclear envelope of the phorbol ester treated NIH-3T3 cells: J Cell Biol 1989, 109:685-695
12. Huang KP, Huang FL, Nakabayashi H, Yoshida Y: Biochemical characterisation of rat brain protein kinase C isoenzymes. J Biol Chem 1988, 263:14839-14845
13. Jaken S, Kiley SC: Purification and characterisation of 3 types of protein kinase C from rabbit brain cytosol. Proc Natl Acad Sci USA 1987, 84:4418-4422
14. 1 rat pituitary cells. J Biol Chem 1990, 265: 15704-15712
15. Herbert JM: Protein kinase C: a key factor in the regulation of tumor cell adhesion to the endothelium. Biochem Pharmacol 1993, 45:527-537
16. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Westal WC, Obeid LM, Fine RL, Hannun YA: Selective regulation of expression of protein kinase C (PKC) isoenzyme in multidrug resistant MCF-7 cells-functional significance of enhanced expression of PKC-α. J Biol Chem 1993, 268:658-664
17. O'Brian CA, Vogel VG, Singletary SE, Ward NE: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 1989, 49:3215-3217
18. Hirai M, Gamou S, Kobayashi M, Shimizu N: Lung cancer cells often express high levels of protein kinase C activity. Japanese J Cancer Res 1989, 80:204-208
19. Pongracz J, Clark P, Neoptolemos JP, Lord JM: Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer 1995, 61:35-39
20. Krongrad A, Bai G: c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells. Cancer Res 1994, 54:203-210
21. Young CY, Murtha PE, Zhang J: Tumor promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol Res 1994, 6:203-210
22. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, Fair WR: Persistent membrane translocation of protein kinase C α during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 1996, 7:419-428
23. Lamm ML, Long DD, Goodwin SM, Lee C: Transforming growth factor β 1 inhibits membrane association of protein kinase C α in a human prostate cancer cell line, PC3. Endocrinology 1997, 138:4657-4664
24. Liu B, Maher RJ, Hanun YA, Porter AT, Honn KV: 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC α. J Natl Can Inst 1994, 86:1145-1151
25. Rusnak JM, Lazo JS: Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. Exp Cell Res 1996, 224:189-199
26. Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R: Overexpress on of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Cancer Res 1996, 56:4137-4141
27. Bashir I, Sikora K, Foster CS: Multidrug resistance and behavioral phenotype of cancer cells. Cell Biol Int 1993, 17:907-917
28. Ke Y, Jing C, Barraclough R, Smith P, Davies MPA, Foster CS: Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. Int J Cancer 1997, 71:832-837
29. Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MBA, Ke Y, Foster CS: Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 1998, 423:19-24
30. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF: Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990, 346:362-365
31. Miwa A, Ueda K, Okada Y: Protein kinase C-independent correlation between P-glycoprotein expression and volume sensitivity of Cl-channel. J Membr Biol 1997, 157:63-69
32. Deshmukh N, Foster CS: Grading prostate cancer. Pathology of the Prostate. Edited by Foster CS. Bostwick DG, eds. Philadelphia, WB Saunders, 1997, pp 191-227
33. van Diest P, van Dam P, Henzen-Logman SC: A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GICCG. J Clin Pathol 1997, 50:801-804
34. Sharpe JC, Abel PD, Gilbertson JA, Brawn P, Foster CS: Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium. Br J Urol 1994, 74:609-616
35. Levy MF, Pocsidio J, Guillem JG, Forde K, Logerfo P, Weinstein IB: Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors. Dis Colon Rectum 1993, 36:913-921
36. Gleason D: Histologic grading and clinical staging of carcinoma of the prostate, in Urologic Pathology. The Prostate. Edited by Tannenbaum M. Philadelphia PA, Lea and Febiger, 1977, pp 171-197
37. MacFarlane DE, Manzel L: Activation of Beta-isoenzyme of protein kinase C (PKC β) is necessary and sufficient for phorbol ester-induced differentiation of HL60 promyelocytes. J Biol Chem 1994, 269:4327-4331
38. Choi PM, Weinstein B: The modulation of growth by HMBA in PKC overproducing HT29 colon cancer cells. Biochem Biophys Res Chem 1991, 181:809-817
39. Borner C, Ueffing M, Jaken S, Parker PJ, Weinstein BI: Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. Possible molecular mechanisms. J Biol Chem 1995, 270:78-86
40. Perletti GP, Folini M, Lin HC, Mischak H, Piccinini F, Tashjian AHJ: Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. Oncogene 1996, 12:847-854
41. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1993, 8:2095-2104
42. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp U, Cooper GM: Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 1997, 17:732-741
43. Luo Z, Diaz B, Marshall MS, Avruch J: An intact Raf zinc finger is required for optimal binding to processedRas and for ras-dependent Raf activation in situ. Mol Cell Biol 1997, 17:46-53
44. Foster CS, McLoughlin J, Bashir I, Abel PD: Markers of the metastatic phenotype in prostate cancer. Hum Pathol 1992, 23:381-394
45. Foster CS, Cornford P, Forsyth L, Djamgoz MBA, Ke Y: The cellular and molecular basis of prostate cancer. Br J Urol 1999, In press
46. Murray NR, Fields AP: Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis. J Biol Chem 1997, 272:27521-27524
47. Kyprianou N, Tu H, Jacobs SC: Apoptotic versus proliferative activities in human benign prostatic hyperplasia: Hum Pathol 1996, 27: 668-675
48. Tu H, Jacobs SC, Borkowski A, Kyprianou N: Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-β1 and bcl-2 expression. Int J Cancer 1996, 69:357-363